Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management

Bibliographic Details
Main Authors:	Li, Wei, Zeng, Su, Yu, Lu-Shan, Zhou, Quan
Format:	Online
Language:	English
Published:	Dove Medical Press 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671798/

Similar Items

Drug interaction: Omeprazole and Phenprocoumon
by: Enderle, Christa, et al.
Published: (2001)

Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
by: Zhou, Yi-Ting, et al.
Published: (2013)

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy
by: Wang, Zhi-Yu, et al.
Published: (2015)

Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone
by: Elazzazy, Shereen, et al.
Published: (2012)

Hypomagnesemia as a potentially life-threatening adverse effect of omeprazole
by: Hansen, Bent-Are, et al.
Published: (2016)

Pharmacokinetic drug-drug interaction and their implication in clinical management
by: Palleria, Caterina, et al.
Published: (2013)

Omeprazole-associated rhabdomyolysis
by: Tanaka, Kumiko, et al.
Published: (2014)

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
by: Chong, Edward, et al.
Published: (2014)

Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns
by: Gao, Chu-Han, et al.
Published: (2014)

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
by: Wedemeyer, Ralph-Steven, et al.
Published: (2014)

Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
by: Mazzari, Andre L. D. A., et al.
Published: (2014)

Corrigendum: Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
by: Mazzari, Andre L. D. A., et al.
Published: (2015)

Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults
by: Braeckman, Rene A., et al.
Published: (2014)

Pharmacokinetic Drug Interaction Studies with Enzalutamide
by: Gibbons, Jacqueline A., et al.
Published: (2015)

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
by: Iida, Hiroshi, et al.
Published: (2012)

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)
by: Sakurai, Kouichi, et al.
Published: (2012)

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
by: Tamura, Takao, et al.
Published: (2012)

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
by: Takao Tamura, Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Published: (2012-01-01)

Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
by: Sternieri, E., et al.
Published: (2005)

What are unintended and adverse consequences?
by: Josué Antonio, Nescolarde-Selva, et al.
Published: ()

An Adverse Drug Interaction of Haloperidol with Levodopa
by: Lucca, Jisha M, et al.
Published: (2015)

Transport through liquid membranes containing omeprazole and lansoprazole
by: Nagappa, A.N., et al.
Published: (2002)

Effects of Omeprazole on Iron Absorption: Preliminary Study
by: Tempel, Mila, et al.
Published: (2013)

Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
by: Mueck, Wolfgang, et al.
Published: (2013)

Incidence, causes, and consequences of preventable adverse drug events: protocol for an overview of reviews
by: Hutton, Brian, et al.
Published: (2016)

Review of Tolvaptan’s Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions
by: Bhatt, Purav R., et al.
Published: (2014)

Pharmacokinetics Interaction between Imatinib and Genistein in Rats
by: Wang, Zhe, et al.
Published: (2015)

Adverse drug reaction profile of oseltamivir in children
by: Dalvi, Prashant S., et al.
Published: (2011)

Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD)
by: Abbasinazari, Mohammad, et al.
Published: (2014)

Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients
by: Chen, Ying, et al.
Published: (2014)

Data-driven prediction of adverse drug reactions induced by drug-drug interactions
by: Ruifeng Liu, et al.
Published: (2017-06-01)

Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
by: Moore, Nicholas, et al.
Published: (2015)

Omeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity
by: Wang, Lianmei, et al.
Published: (2016)

Pharmacokinetic Drug-Drug Interaction and Responsible Mechanism between Memantine and Cimetidine
by: Young A. Choi, et al.
Published: (2018-08-01)

Extraction of Pharmacokinetic Evidence of Drug–Drug Interactions from the Literature
by: Kolchinsky, Artemy, et al.
Published: (2015)

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
by: Jung, Jin Ah, et al.
Published: (2015)

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
by: Lamorde, M
Published: (2012)

Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications
by: Shannon, Richard J., et al.
Published: (2013)

Pharmacokinetics, chemical interactions, and toxicological risk assessment in perspective.
by: Blancato, J N
Published: (1994)

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
by: Rizzoli, René, et al.
Published: (2011)